Health Care | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology
NASDAQ | Common Stock
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics.
The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia.
It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2.
It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences.
The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021.
AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 10, 22 | -1.17 Decreased by -233.90 K% | -0.77 Decreased by -51.95% |
| Aug 12, 22 | -1.18 Decreased by -5.80 K% | -0.68 Decreased by -73.53% |
| May 16, 22 | -1.19 Decreased by -1.60 K% | -0.34 Decreased by -250.00% |
| Mar 28, 22 | -0.34 Decreased by -3.50 K% | -0.17 Decreased by -100.00% |
| Nov 10, 21 | -0.00 Increased by +99.17% | -0.51 Increased by +99.90% |
| Aug 11, 21 | -0.02 Increased by +71.43% | - |
| May 10, 21 | -0.07 Increased by +92.31% | - |
| Mar 25, 21 | 0.01 Decreased by -96.43% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 22 | 0.00 Decreased by N/A% | -6.24 M Decreased by -13.17 K% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -5.08 M Decreased by -275.52% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -3.54 M Increased by +10.78% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -1.81 M Decreased by -655.21% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 21 | 0.00 Decreased by N/A% | -47.00 K Increased by +97.67% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 21 | 0.00 Decreased by N/A% | -1.35 M Increased by +41.55% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 21 | 0.00 Decreased by N/A% | -3.96 M Increased by +52.45% | Decreased by N/A% - |
| Dec 31, 20 | 0.00 Decreased by -100.00% | 326.00 K Decreased by -66.50% | Increased by +N/A% Increased by +N/A% |